Mowoot, a start-up and CataloniaBio & HealthTech member, has published its first international clinical trial showing the efficacy and safety of the medical device in treating chronic constipation, regardless of the cause.
It was a multi-centre study carried out with 92 patients over 2 years, funded through the EU Horizon 2020 programme.It was led by Doreen McClurg, a benchmark in the field of neurogenic bowel dysfunction at Glasgow Caledonian University, and Immaculada Herrero-Fresneda, co-founder and CSO of Mowoot.
The results have been published in the journal Clinical and Transalational Gastroenterology.
In addition to the publication of this clinical trial, the company has been entering EU markets recently and is preparing public healthcare reimbursement in Germany and the United Kingdom.
El equipo de investigadores observó cambios en el...
El gen AtCDF3 promueve una mayor producción de az...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del si...
La revista ‘Nature Protocols’ selecciona esta técnica como “pro...
